Title:Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling
Volume: 10
Author(s): Kenneth Blum*, Thomas McLaughlin, Edward J. Modestino, David Baron, Abdalla Bowirrat, Raymond Brewer , Bruce Steinberg, Alphonso K. Roy, Marcelo Febo, Rajendra D. Badgaiyan and Marks S. Gold
Affiliation:
- Western University Health Sciences, Pomona, CA,United States
Keywords:
Lucid dreams, pro-dopamine regulation (KB220), functional connectivity, neuroplasticity, genetic addiction risk
severity (GARS), dopaminergic homeostatic signaling.
Abstract: During Lucid Dreams, the dreamer is aware, experiences the dream as if fully awake,
and may control the dream content. The dreamer can start, stop, and restart dreaming, depending
on the nature and pleasantness of the dream. For patients with Reward Deficiency Syndrome (RDS)
behaviors, like Attention Deficit Hyperactivity Disorder (ADHD), Tourette's-Syndrome, and
Posttraumatic Stress Disorder (PTSD), the dream content may be pleasant, unpleasant, or terrifying.
A sample of psychiatric center patients identified as having RDS reported the effectiveness of
a neuronutrient, dopamine agonist, KB200Z, in combating terrifying, lucid dreaming. These reports
motivated the study of eight clinical cases with known histories of substance abuse, childhood
abuse, and PTSD. The administration of KB200Z, associated with eliminating unpleasant or
terrifying lucid dreams in 87.5% of the cases. Subsequently, other published cases have further
established the possibility of the long-term elimination of terrifying dreams in PTSD and ADHD
patients. Induction of dopamine homeostasis may mitigate the effects of neurogenetic and epigenetic
changes in neuroplasticity, identified in the pathogenesis of PTSD and ADHD. The article explores
how relief of terrifying lucid dreams may benefit from modulation of dopaminergic signaling
activated by the administration of a neuronutrient. Recently, precision formulations of the
KB220 neuronutrient guided by Genetic Addiction Risk Severity (GARS) test results have been
used to repair inheritable deficiencies within the brain reward circuitry. The proposition is that improved
dopamine transmodulational signaling may stimulate positive cognitive recall and subsequently
attenuate the harmful epigenetic insults from trauma.
